Clara Forcada , María Teresa Gómez-Hernández , Cristina E. Rivas , Marta G. Fuentes , Óscar Colmenares , Mario Manama , José Luis Aranda , Marta Rodríguez , Mercedes Sánchez , Marcelo F. Jiménez
{"title":"Impact of minimally invasive surgical approach on oncological completeness of resection in lung cancer surgery","authors":"Clara Forcada , María Teresa Gómez-Hernández , Cristina E. Rivas , Marta G. Fuentes , Óscar Colmenares , Mario Manama , José Luis Aranda , Marta Rodríguez , Mercedes Sánchez , Marcelo F. Jiménez","doi":"10.1016/j.suronc.2025.102310","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>Oncological radicality, defined as complete resection, is essential in lung cancer surgery. This study aimed to compare the oncological quality of anatomical lung resections performed via video-assisted thoracoscopic surgery (VATS) versus robotic-assisted thoracic surgery (RATS), focusing on completeness of resection. Secondary objectives included lymphadenectomy quality, nodal upstaging, residual disease, and the number of dissected lymph node stations and retrieved lymph nodes.</div></div><div><h3>Methods</h3><div>A prospective single-center study included consecutive patients undergoing minimally invasive anatomical lung resection for lung cancer (September 2023–April 2025). Overlap weighting based on propensity scores—calculated using histology, clinical T and N stage, and extent of resection—was applied. Outcomes related to oncological radicality were compared between the VATS and RATS groups using appropriate statistical tests based on variable type and distribution.</div></div><div><h3>Results</h3><div>Of 358 patients, 255 met the inclusion criteria (84 RATS, 171 VATS). The rates of complete, incomplete, and uncertain resection were 62.0 %, 3.5 %, and 34.5 %, respectively. After overlap weighting, no significant differences were observed between RATS and VATS in complete resection (66.5 % vs. 60 %, p = 0.557), residual disease (2.17 % vs. 1.92 %, p = 0.802), adequate lymphadenectomy (70.7 % vs. 61.8 %, p = 0.181), or nodal upstaging (19.7 % vs. 11.3 %, p = 0.087). However, RATS yielded a higher number of mediastinal nodal stations dissected (median: 4 vs. 3, p < 0.001) and lymph nodes retrieved (median: 9 vs. 7, p < 0.001).</div></div><div><h3>Conclusions</h3><div>RATS and VATS achieved similar oncological radicality. However, RATS was associated with more extensive lymphadenectomy, potentially improving staging accuracy.</div></div>","PeriodicalId":51185,"journal":{"name":"Surgical Oncology-Oxford","volume":"64 ","pages":"Article 102310"},"PeriodicalIF":2.1000,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgical Oncology-Oxford","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0960740425001252","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/10/28 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives
Oncological radicality, defined as complete resection, is essential in lung cancer surgery. This study aimed to compare the oncological quality of anatomical lung resections performed via video-assisted thoracoscopic surgery (VATS) versus robotic-assisted thoracic surgery (RATS), focusing on completeness of resection. Secondary objectives included lymphadenectomy quality, nodal upstaging, residual disease, and the number of dissected lymph node stations and retrieved lymph nodes.
Methods
A prospective single-center study included consecutive patients undergoing minimally invasive anatomical lung resection for lung cancer (September 2023–April 2025). Overlap weighting based on propensity scores—calculated using histology, clinical T and N stage, and extent of resection—was applied. Outcomes related to oncological radicality were compared between the VATS and RATS groups using appropriate statistical tests based on variable type and distribution.
Results
Of 358 patients, 255 met the inclusion criteria (84 RATS, 171 VATS). The rates of complete, incomplete, and uncertain resection were 62.0 %, 3.5 %, and 34.5 %, respectively. After overlap weighting, no significant differences were observed between RATS and VATS in complete resection (66.5 % vs. 60 %, p = 0.557), residual disease (2.17 % vs. 1.92 %, p = 0.802), adequate lymphadenectomy (70.7 % vs. 61.8 %, p = 0.181), or nodal upstaging (19.7 % vs. 11.3 %, p = 0.087). However, RATS yielded a higher number of mediastinal nodal stations dissected (median: 4 vs. 3, p < 0.001) and lymph nodes retrieved (median: 9 vs. 7, p < 0.001).
Conclusions
RATS and VATS achieved similar oncological radicality. However, RATS was associated with more extensive lymphadenectomy, potentially improving staging accuracy.
目的:肿瘤根治性,定义为完全切除,在肺癌手术中是必不可少的。本研究旨在比较通过视频辅助胸腔镜手术(VATS)和机器人辅助胸外科手术(RATS)进行的解剖性肺切除术的肿瘤学质量,重点是切除的完整性。次要目标包括淋巴结切除术的质量、淋巴结的分期、残留病变、淋巴结清扫和淋巴结回收的数量。方法:一项前瞻性单中心研究纳入了2023年9月至2025年4月连续接受微创解剖性肺癌肺切除术的患者。使用基于倾向评分的重叠加权-使用组织学,临床T和N分期以及切除程度计算。采用基于变量类型和分布的适当统计检验,比较VATS组和RATS组与肿瘤根治性相关的结果。结果:358例患者中,255例符合纳入标准(rat 84例,VATS 171例)。完全切除、不完全切除和不确定切除的比例分别为62.0%、3.5%和34.5%。重叠加权后,大鼠和VATS在完全切除(66.5% vs. 60%, p = 0.557)、残留病变(2.17% vs. 1.92%, p = 0.802)、充分淋巴结切除术(70.7% vs. 61.8%, p = 0.181)或淋巴结分期(19.7% vs. 11.3%, p = 0.087)方面无显著差异。然而,大鼠获得了更高数量的纵隔淋巴结清扫(中位数:4比3,p)。然而,RATS与更广泛的淋巴结切除术相关,可能提高分期准确性。
期刊介绍:
Surgical Oncology is a peer reviewed journal publishing review articles that contribute to the advancement of knowledge in surgical oncology and related fields of interest. Articles represent a spectrum of current technology in oncology research as well as those concerning clinical trials, surgical technique, methods of investigation and patient evaluation. Surgical Oncology publishes comprehensive Reviews that examine individual topics in considerable detail, in addition to editorials and commentaries which focus on selected papers. The journal also publishes special issues which explore topics of interest to surgical oncologists in great detail - outlining recent advancements and providing readers with the most up to date information.